Monocyte human leukocyte antigen-DR expression and the prognosis in patients with acute respiratory distress syndrome

LIU Ling,QIU Haibo,YANG Yi
DOI: https://doi.org/10.3969/j.issn.1671-5403.2009.02.009
2009-01-01
Chinese Journal of Multiple Organ Diseases in the Elderly
Abstract:Objective To investigate the relationship between monocyte human leukocyte antigen-DR (HLA-DR) expression on peripheral monocytes and the prognosis in patients with acute respiratory distress syndrome (ARDS). Methods Seventy-six patients with ARDS admitted to this hospital between July 2004 and June 2005 were included in this study. After the diagnosis of ARDS,monocytes HLA-DR expression and immunophenotype of lymphocyte (CD3,CD4,CD8) were measured on the 1st and the 7th days of ARDS using flow cytometry. On the 1st day of ARDS,the following variables were recorded:age,sex,Acute Physiology and Chronic Health Evaluation (APACHE)Ⅱ score,heart rate,respiratory rate,mean arterial pressure,PaO2/FiO2,arterial blood pH and lactate,peripheral blood haemoglobin,platelet and leukocyte counts and the number of organs with function failure. The patients were divided into survivors and non-survivors according to whether they died within the 28 day period following the onset of ADRS. Results The monocyte HLA-DR expression on the 1st and the 7th days of ARDS were not different between survivors and non-survivors. In the non-survivors,the monocyte HLA-DR expression on the 7th day of ARDS was significantly lower than that on the 1st day. The survival time in patients with the 1st day HLA-DR >30% was much longer than that in patients with the 1st day HLA-DR ≤ 30%. The 28-day mortality of patients with the 1st day HLA-DR ≤ 30% was 67%,which was slightly higher than that of patients with the 1st day HLA-DR >30% (42%). Taking the 1st day monocytes HLA-DR expression ≤30% as a predictor of death,its sensitivity was 97% and specificity was 17%. The area under ROC curve which predicted prognosis using 1st day HLA-DR was only 0.553 (P = 0.618),while the area under ROC curve which predicted prognosis using the changes of HLA-DR expression on the 1st day and the 7th day was 0.830 (P < 0.01). No correlation was found between expression of HLA-DR on 1st day and 7th day and APACHEⅡ score or number of organs with function failure. The survival time of severe infection-induced ARDS patients were lower than that of non-infection induced ARDS patients. Conclusion Monocyte HLA-DR expression ≤ 30% points to poor prognosis. The decline of HLA-DR expression may be a useful prognostic marker of outcome.
What problem does this paper attempt to address?